[1]
“Usage of Nivolumab - Platinum Containing STAT1 Molecule for Suppression PD-1/PD-L1 Genes in PD-1/PD-L1 Expressing Cancer Cells”, GJMR, vol. 22, no. B2, pp. 55–63, Apr. 2022, Accessed: Jun. 02, 2026. [Online]. Available: https://medicalresearchjournal.org/index.php/GJMR/article/view/102179